ArticleBiomedicines2019

Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment.

Robert Owen Dillman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.